Publications found:
105,716
Sort by:
REGENERON - Riding High on the Back of Eylea...
US$ 90.00
... ’s ability to buffer the setbacks in the pipeline. In today’s 2Q12 earnings, Regeneron (REGN) reported sales of $194m way above street expectations (our ...
July 2012
4 pages
VIVUS – Qsymia’s Launch and Ex-US Partnership = Growth Drivers
US$ 140.00
... launch by 4Q12 ahead of rival drug, Arena/Eisai's Belviq (loracaserin, 5-HT2C receptor agonist) should give Vivus (VVUS) the first mover advantage, as Qsymia ... , please read our report released on July 19, 2012 on VVUS, titled “Qsymia’s Launch and Ex-US Partnership = Growth Drivers
July 2012
3 pages
US Infectious Disease Testing Market Forecasts and Supplier Shares (DataPack)
US$ 5,520.00
This report presents comprehensive data for the US infectious disease testing market, including: The 2010-2018 test volume and sales forecasts for nearly 80 infectious diseases performed in US hospitals, blood banks, physician offices, public health and commercial laboratories. The 2010 ...
July 2012
Pet Supplies and Pet Care Products in the U.S., 9th Edition
US$ 4,850.00
... with functional (health) and indulgence (pampering) attributes appealing to people and pets alike. Accordingly, stylish, distinctly “human-style” products and brands ... market research collection and analyst expertise, Pet Supplies and Pet Care Products in the U.S, 9th Edition provides category breakouts and ...
July 2012
322 pages
